Why earnouts matter in cannabis M&A
Earnouts are a common risk-allocation provision in cannabis and hemp mergers and acquisitions used to bridge the business-value gap between a business owner and an acquirer.
Earnouts are a common risk-allocation provision in cannabis and hemp mergers and acquisitions used to bridge the business-value gap between a business owner and an acquirer.
In this Executive Webinar on Sept. 26 at 2 p.m. ET, CEO Jessica Billingsley will join Investor Intelligence Analyst Mike Regan to discuss Akerna’s outlook and the role technology can play in addressing the current vape crisis.
Cannabis companies are issuing equity, debt and warrants for acquisitions at a rapid pace right now, moves that require answers to key questions for keen investors.
Anecdotal evidence points to a decline in employee theft in the marijuana space, but it’s safe to assume it hasn’t been eradicated.
Due to the highly fragmented legal and regulatory landscape of the cannabis industry, the sources from which a company generates revenues can have a huge impact on a company’s opportunity and risk profile.
Latin America has become a key target for cannabis companies looking to expand internationally. But, as Marijuana Business Daily’s International Analyst Alfredo Pascual notes in a new report, the “devil is in the details.”
Capital raises in the cannabis industry may be roughly the same in terms of absolute numbers, but data shows the amount being raised has grown significantly.
We’ve all heard the idiom “mind your p’s and q’s.” But in the business world, p’s and q’s speaks to how we drive revenue: price and quantity.
Momentum continues to build for medical cannabis legalization around the globe, prying open new markets and tens of billions of dollars in business opportunities for entrepreneurs and companies with global ambitions.